Generalized anxiety disorder trials recruiting in New York

All Generalized anxiety disorder trials nationally

Cities in New York

Recruiting trials in New York

• A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
  NCT07759128 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
  NCT07767903 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: Jamaica
• RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
  NCT07489651 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · New York: New York
• Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
  NCT06701903 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · New York: Brooklyn, Buffalo, Staten Island
• Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
  NCT06480383 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · New York: Brooklyn
• Triage Survey for Psychiatry Research Eligibility
  NCT05800925 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · New York: New York, The Bronx